Zobrazeno 1 - 10
of 68
pro vyhledávání: '"David Loach"'
Autor:
Maria Queralt Salas, Arjun Datt Law, Wilson Lam, Zeyad Al-Shaibani, David Loach, Dennis (Dong Hwan) Kim, Fotios V. Michelis, Santhosh Thyagu, Rajat Kumar, Jeffrey Howard Lipton, Jonas Mattsson, Auro Viswabandya
Publikováno v:
Clinical Hematology International, Vol 1, Iss 2 (2019)
Haploidentical stem cell transplantation (haploSCT) has greatly improved access to curative treatment for myeloid malignancies in patients without suitable matched sibling/unrelated donors. We investigated the safety and efficacy of haploSCT after re
Externí odkaz:
https://doaj.org/article/d1fb35b8e0cd4c28aa1183db06145608
Autor:
Ram V Nampoothiri, Fotios V. Michelis, Auro Viswabandya, Jeffrey H. Lipton, Zeyad Al-Shaibani, Carol Chen, Dennis Dong Hwan Kim, Jonas Mattsson, Arjun Datt Law, Wilson Lam, Rajat Kumar, David Loach
Publikováno v:
European Journal of Haematology. 105:24-29
Introduction Therapy-related acute lymphoblastic leukemia (t-ALL) is an increasingly recognized subset of therapy-related acute leukemia. There are limited data on the role of allogeneic hematopoietic stem cell transplantation (HSCT) in t-ALL. Recent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c35f99fda10ff780c26fa290644d2ca4
https://doi.org/10.1111/ejh.13403
https://doi.org/10.1111/ejh.13403
Autor:
Fotios V. Michelis, Santhosh Thyagu, Alexander Js Bacopoulos, Lina Ho, David Loach, Celina Dara, Anjie Yang, Pamela Ng, Hans A. Messner, Jeffrey H. Lipton, Dennis Dong Hwan Kim, Uday Deotare, Auro Viswabandya
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:33-39
At our institution, tacrolimus is used as a second-line agent for the prevention and treatment of graft-versus-host-disease in the allogeneic hematopoietic stem cell transplantation (HSCT) unit after patients have experienced a serious or intolerable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61bdc660a4377c495c912128adad81ff
https://doi.org/10.1177/1078155220908948
https://doi.org/10.1177/1078155220908948
Publikováno v:
Blood research
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea7171324d357cb4f4060a4c9d986228
http://europepmc.org/articles/PMC6942146
http://europepmc.org/articles/PMC6942146
Autor:
Auro Viswabandya, Wilson Lam, Maria Queralt Salas, Eshetu G. Atenafu, Rajat Kumar, Shruti Prem, David Loach, Zeyad Al-Shaibani, Jeffrey H. Lipton, Arjun Datt Law, Dennis Dong Hwan Kim, Fotios V. Michelis, Jonas Mattsson
Publikováno v:
European Journal of Haematology. 103:510-518
Objectives We aimed to study the efficacy of reduced intensity conditioning (RIC) allo-HSCT combined with anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) for graft-versus-host disease (GVHD) prophylaxis in AML. Methods One h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c99d310fb4131f16141fd697c065d83
https://doi.org/10.1111/ejh.13321
https://doi.org/10.1111/ejh.13321
Autor:
Rajat Kumar, Dennis Dong Hwan Kim, Jonas Mattsson, David Loach, Arjun Datt Law, Zeyad Al-Shaibani, Carol Chen, Wilson Lam, Fotios V. Michelis, Jeffrey H. Lipton, Auro Viswabandya, Ram V Nampoothiri
Publikováno v:
Hematology/Oncology and Stem Cell Therapy.
Background/Objective Existing literature on allogeneic hematopoietic stem cell transplantation (allo-HSCT) in therapy-related acute myeloid leukemia (t-AML) is confounded by the inclusion of patients with secondary AML and t-MDS. We aim to report our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5347e69f0abbd50af5f1f4e2e39e37ab
https://doi.org/10.1016/j.hemonc.2021.03.003
https://doi.org/10.1016/j.hemonc.2021.03.003
Autor:
Uday Deotare, Aamir Azeem, Eshetu G. Atenafu, Hans A. Messner, Dennis Dong Hwan Kim, Auro Viswabandya, Jeffrey H. Lipton, Rebecca M. Grunwald, Fotios V. Michelis, Vikas Gupta, John Kuruvilla, Rouslan Kotchetkov, David Loach
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:945-951
To review the emergence of secondary malignancies (SMs) in recipients of allogeneic hematopoietic cell transplantation (HCT), we documented the occurrence of SMs in 2415 allogeneic HCT recipients, ages 18 to 71, in a single center over 4 decades. SMs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a3edae517730a02b10f97706b81f0a8
https://doi.org/10.1016/j.bbmt.2017.02.015
https://doi.org/10.1016/j.bbmt.2017.02.015
Autor:
Arjun Datt Law, Wilson Lam, Jeffrey H. Lipton, Ram Vasudevan Nampoothiri, Carol Chen, Auro Viswabandya, Zeyad Al-Shaibani, Dennis Dong Hwan Kim, Jonas Mattsson, Fotios V. Michelis, Rajat Kumar, David Loach
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S107-S108
Background Therapy related acute myeloid leukemia (t-AML) constitutes a subset of AML that has an increased proportion of high risk cytogenetic and molecular features, poorer response to therapy, higher relapse and decreased overall survival. Allogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1b58c6be4118d84880c4b897899421e
https://doi.org/10.1016/j.bbmt.2019.12.614
https://doi.org/10.1016/j.bbmt.2019.12.614
Autor:
Fotios V. Michelis, Rajat Kumar, Auro Viswabandya, David Loach, Shruti Prem, Zeyad Al-Shaibani, Maria Queralt Salas, Eshetu G. Atenafu, Arjun Datt Law, Jeffrey H. Lipton, Wilson Lam, Dennis Dong Hwan Kim, Jonas Mattsson
Publikováno v:
Bone marrow transplantation. 55(9)
The efficacy of posttransplant cyclophosphamide (PTCy) and antithymocyte globulin (ATG) in controlling GVHD has been previously reported. We aim to study the safety and efficacy of the use of dual T-cell depletion with ATG and PTCy for peripheral blo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cbc909b4e99ffbaa2deebd895a78abe
https://pubmed.ncbi.nlm.nih.gov/32024990
https://pubmed.ncbi.nlm.nih.gov/32024990
Autor:
Rajat Kumar, Fotios V. Michelis, Arjun Datt Law, David Loach, Maria Queralt Salas, Dennis Dong Hwan Kim, Jeffrey H. Lipton, Auro Viswabandya, Wilson Lam, Zeyad Al-Shaibani, Jonas Mattsson
Publikováno v:
European journal of haematologyREFERENCES. 103(6)
Background There remains a significant mortality in recipients with MF who undergo allogeneic stem cell transplant (allo-HSCT). The combination of antithymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) provides good control of graft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddfe1f2b4ed5c7b03ffc10c7dffea7d2
https://pubmed.ncbi.nlm.nih.gov/31514253
https://pubmed.ncbi.nlm.nih.gov/31514253